These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 23293271)

  • 1. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal cancer in Italy, 2009 survey.
    Zorzi M; Baracco S; Fedato C; Grazzini G; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):55-77. PubMed ID: 22166350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer in Italy: 2007 survey.
    Zorzi M; Fedato C; Naldoni C; Sassatelli R; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
    Epidemiol Prev; 2009; 33(3 Suppl 2):57-74. PubMed ID: 19776487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer in Italy: 2008 survey.
    Zorzi M; Baracco S; Fedato C; Grazzini G; Naldoni C; Sassoli dé Bianchi P; Senore C; Visioli CB; Cogo C
    Epidemiol Prev; 2010; 34(5-6 Suppl 4):53-72. PubMed ID: 21220837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer in Italy: 2011-2012 survey.
    Zorzi M; Da Re F; Mantellini P; Naldoni C; Sassoli De'Bianchi P; Senore C; Turrin A; Visioli CB; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):93-107. PubMed ID: 26405781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer in Italy: 2006 survey.
    Zorzi M; Falcini F; Fedato C; Grazzini G; de' Bianchi PS; Senore C; Vettorazzi M; Visioli C; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):55-68. PubMed ID: 18770995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer in Italy: 2004 survey.
    Zorzi M; Grazzini G; Senore C; Vettorazzi M
    Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
    Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
    Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey.
    Turrin A; Zorzi M; Giorgi Rossi P; Senore C; Campari C; Fedato C; Naldoni C; Anghinoni E; Carrozzi G; Sassoli De' Bianchi P; Zappa M;
    Prev Med; 2015 Dec; 81():132-7. PubMed ID: 26358527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering people a choice for colorectal cancer screening.
    Senore C; Ederle A; Benazzato L; Arrigoni A; Silvani M; Fantin A; Fracchia M; Armaroli P; Segnan N
    Gut; 2013 May; 62(5):735-40. PubMed ID: 22442162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.
    Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N
    J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography screening in Italy: 2005 survey and 2006 preliminary data.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):7-22. PubMed ID: 18770992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
    Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
    Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.